John Deflice, myeloma patient, with backdrop of ASH conference in Orlando 2019

Shrimp Options

John DeFlice |

“Anyway, like I was sayin’, shrimp is the fruit of the sea. You can barbecue it, boil It, broil it, bake it, sauté it. Dey’s un, shrimp-kabobs, shrimp creole, shrimp gumbo, pan fried, deep fried, stir-fried. There’s pineapple shrimp, lemon shrimp, coconut shrimp, pepper shrimp, shrimp soup, shrimp stew, shrimp salad, shrimp and potatoes, shrimp […]

Dara, the new Bacon…I mean, Beacon of Myeloma

Yelak Biru |

One of the late-breaking abstracts presented by Dr. Saad Usamani compared Kyprodlis and dexamethason (Kd) with Kd and daratumumab. There were many trial results that were presented at ASH that showed Dara makes many drugs better. Combining Dara with KRd seems to result in an “unprecedented” level of response and MRD negative response for newly […]

Valarie Traynham on backdrop of American Society of Hematology

It’s All About That Dara, That Dara!

Valarie Traynham |

Daratumumab (dara), trade name Darzalex, received breakthrough therapy drug status in 2013 for multiple myeloma. Daratumumab is a monoclonal antibody directed against CD38, a molecule present on myeloma cells. Since it’s inception, it has taken the myeloma world by storm. In late 2015 daratumumab was approved by the U.S. Food and Drug Administration (FDA) for treatment of […]